Skip to main content
. 2021 Oct 20;8:739633. doi: 10.3389/fcvm.2021.739633

Table 1.

Patient characteristics.

Mean ± SD, median (interquartile), or n (%)
Age, years 60 ± 9
Male 81 (75)
BMI, kg/m2 26.1 ± 4.8
Heart rate at CTCA, bpm 57 ± 6
Race/ethnics
Chinese, n (%) 86 (80)
Indian/Malay, n (%) 16 (15)
Other Asians, n (%) 6 (5)
Risk factors
Hypertension, n (%) 69 (64)
Hyperlipidemia, n (%) 76 (70)
Diabetes, n (%) 30 (28)
Current smoker, n (%) 16 (15)
Ex-smoker, n (%) 9 (8)
Vital signs
SBP, mmHg 134 ± 17
DBP, mmHg 77 ± 11
Laboratory measures
Hemoglobin, g/dl 13.9 ± 1.3
Hematocrit, % 41.9 ± 3.4
Creatinine, mmol/L 0.076 ± 0.019
Medications
Aspirin, n (%) 94 (87)
Beta-blocker, n (%) 54 (50)
Nitrate, n (%) 72 (67)
Statins, n (%) 91 (84)
ACEI/ARB, n (%) 31 (29)
Clopidogrel, n (%) 93 (86)
Calcium channel blockers, n (%) 23 (21)
Other medications, n (%) 52 (48)
Left ventricular mass, g 115 ± 31
Agatston score 275 (108, 502)

BMI, body mass index; CTCA, computed tomography coronary angiography; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACEI, angiotensin-converting enzyme injection; ARB, angiotensin receptor blocker.